Human Immunology Biosciences Launches to Lead Clinical Immunology into Its Next Chapter with $120 Million Financing

Human Immunology Biosciences Launches to Lead Clinical Immunology into Its Next Chapter with $120 Million Financing

Related Keywords

China ,South Korea ,Massachusetts ,United States ,Brian Kotzin ,Jaideep Dudani ,Paul Berns ,Fred Cohen ,Mark Murcko ,Christina Carlson ,Chris Goodnow ,Carol Suh ,John Davis ,Matthew Albert ,John Lowe ,Kristin Hogquist ,Gregg Silverman ,Barbara Krebs Pohl ,Mark Daly ,Travis Murdoch ,Rachel Mears ,Andrew Luster ,Mamdouhas Bobst ,Division Of Rheumatology ,Langone Health ,Garvan Institute Of Medical Research ,University Of Minnesota ,Head Of Portfolio Development ,Department Of Medicine ,Head Of Early Clinical Development At Pfizer ,Clinical Development ,Monograph Capital ,Jeito Capital ,Human Immunology Biosciences ,Bio Chairman ,Managing Director ,Greater China ,Chief Executive Officer ,Chief Translational Officer ,General Counsel ,Chief Business Officer ,Senior Vice President ,Portfolio Development ,Vice President ,Monograph Capital Partners ,Founding Chief Scientific Officer ,Dewpoint Therapeutics ,Relay Therapeutics ,Scientific Advisory Board ,Founding Chief ,Translational Genetics Unit ,Massachusetts General Hospital ,Early Clinical Development ,Executive Director ,Garvan Institute ,Medical Research ,Clinical Pharmacology ,Associate Director ,Nektar Therapeutics ,Senior Director ,Internal Medicine ,